Diffuse Large B Cell Lymphoma Clinical Trials in Xiamen, Fujian
5 recruitingXiamen, Fujian, China
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Diffuse Large B Cell Lymphoma
Merck Sharp & Dohme LLC1,046 enrolled246 locationsNCT06717347
Recruiting
Phase 3
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Diffuse Large B Cell Lymphoma
Genmab360 enrolled177 locationsNCT06508658
Recruiting
Phase 2
Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL
Diffuse Large B Cell LymphomaRelapsed and Refractory
The First Affiliated Hospital of Xiamen University22 enrolled1 locationNCT06651853
Recruiting
Phase 2
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma
The First Affiliated Hospital of Xiamen University38 enrolled1 locationNCT06151080
Recruiting
Phase 2
AZA Combined With RCHOP in P53-mutated DLBCL.
DLBCL - Diffuse Large B Cell LymphomaTP53
The First Affiliated Hospital of Xiamen University52 enrolled1 locationNCT06158399